MAPT and Alzheimer disease: Using cellular and transgenic models of AD, HDAC6 was found to promote aspects of the AD phenotype, and this was proposed to occur via HDAC6 interaction with Tau (Govindarajan et al., 2013; Zhang L. et al., 2014; Tseng et al., 2017).